|
ATP5B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.89879999957077E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.357660E-04 |
| Normal-vs-Stage2 |
2.310300E-02 |
| Normal-vs-Stage3 |
5.230400E-02 |
| Normal-vs-Stage4 |
1.781860E-02 |
| Stage1-vs-Stage2 |
6.433000E-01 |
| Stage1-vs-Stage3 |
9.099600E-01 |
| Stage1-vs-Stage4 |
4.601400E-01 |
| Stage2-vs-Stage3 |
7.837200E-01 |
| Stage2-vs-Stage4 |
7.187200E-01 |
| Stage3-vs-Stage4 |
5.849000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.22409999994788E-06 |
| Normal-vs-AfricanAmerican |
6.444600E-03 |
| Normal-vs-Asian |
2.117200E-01 |
| Caucasian-vs-AfricanAmerican |
4.949200E-01 |
| Caucasian-vs-Asian |
8.853000E-01 |
| AfricanAmerican-vs-Asian |
6.746200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.37609999967859E-07 |
| Normal-vs-Female |
3.918100E-03 |
| Male-vs-Female |
5.914000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.441790E-03 |
| Normal-vs-Extreme_Weight |
1.381320E-04 |
| Normal-vs-Obese |
7.787700E-04 |
| Normal-vs-Extreme_Obese |
5.570400E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.030800E-01 |
| Normal_Weight-vs-Obese |
7.890400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.688000E-01 |
| Extreme_Weight-vs-Obese |
8.653400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.912400E-01 |
| Obese-vs-Extreme_Obese |
4.317400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.087770E-01 |
| Normal-vs-Age(41-60Yrs) |
3.8989999999739E-06 |
| Normal-vs-Age(61-80Yrs) |
2.562500E-04 |
| Normal-vs-Age(81-100Yrs) |
5.723900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.665400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.070800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.362800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.764600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.022600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.199200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.65559999995868E-07 |
| Normal-VS-Type2 PRCC |
4.240300E-02 |
| Normal-VS-KIRP CIMP |
2.598000E-04 |
| Normal-VS-Unclassified PRCC |
2.342400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.027810E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.112100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.457230E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.944180E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.539600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.068200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.176000E-03 |
| Normal-vs-N1 |
1.878730E-03 |
| Normal-vs-N2 |
1.012370E-04 |
| N0-vs-N1 |
3.202000E-01 |
| N0-vs-N2 |
3.929200E-01 |
| N1-vs-N2 |
7.231800E-01 |
|
|
